Clinical trial

HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL

NCT03947775

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-09-01

PhasePHASE2

Study timeline

Study start (estimated)2022-09-01Date precision: day

Registry last updated2022-06-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Anal Intraepithelial Neoplasiaunresolved

Anal Cancerunresolved

Human Papilloma Virusunresolved

Interventions

9-valent HPV vaccinationDRUG

Sponsors & collaborators

University Health Network, Torontolead sponsor

Merck Sharp & Dohme LLCcollaborator

Mapped research locations

VancouverBritish Columbia, Canada2 TorontoOntario, Canada1 OttawaOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03947775 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.